Related Experiment Videos
Cytokines as drug targets.
1Signal Pharmaceuticals Inc, 5555 Oberlin Drive, San Diego, CA 92121, USA. danderso@signalpharm.com
Idrugs : the Investigational Drugs Journal
|July 15, 2005
Summary
Cytokine-based therapies are crucial for treating inflammatory and autoimmune diseases like rheumatoid arthritis and Crohn's disease. This conference highlighted advancements in cytokine research, drug discovery, and clinical applications for various conditions.
Area of Science:
- Immunology and Pharmacology
- Biomedical Research
Background:
- Cytokines are key mediators in cancer, metabolic, autoimmune, and inflammatory diseases.
- Cytokine-based drugs and anticytokine therapies represent a significant therapeutic class.
Purpose of the Study:
- To discuss new developments in the basic research of cytokines.
- To cover advancements in the drug discovery and clinical development of cytokine-based therapies.
Main Methods:
- Review of current cytokine-based drugs and therapies.
- Focus on new developments presented at a conference.
Main Results:
- Interferons are used for viral diseases and cancers.
- Anti-tissue necrosis factor therapies show efficacy in rheumatoid arthritis and Crohn's disease.
- Thalidomide is used for leprosy, cancers, and autoimmune diseases.
Conclusions:
- Cytokine-based drugs are increasingly important for managing various diseases.
- Continued research and development in this area are vital for therapeutic advancements.